Chicago Classification v4.0 (CCv4.0) is the updated classification scheme for esophageal motility disorders using metrics from high-resolution manometry (HRM). Fifty-two diverse international experts separated into seven working sub-groups utilized formal validated methodologies over two-years to develop CCv4.0. Key updates in CCv.4.0 revolve around a more rigorous and expansive protocol that incorporates different positions and provocative testing, a refined definition of esophago-gastric junction (EGJ) outflow obstruction (EGJOO), an increased threshold for the diagnosis of ineffective esophageal motility and inclusion of a description of baseline EGJ metrics. Further, the CCv4.0 sought to define motility disorder diagnoses as conclusive and inconclusive based on associated symptoms, the use of provocative testing and corroborating supportive testing with barium esophagram with tablet and/or functional lumen imaging probe. These changes attempt to minimize ambiguity in prior iterations of Chicago Classification and provide more standardized and rigorous criteria for patterns of disorders of peristalsis and obstruction at the EGJ.
Read More

Guidelines
Endoscopy
BSG interim technical review and position on the use of lumen opposing metal stents during therapeutic endoscopic ultrasound following the urgent medical device recall
clinical-resource/Lumen-opposing-metal-stents-review

Clinical Resources
Position Statements
British Society of Gastroenterology and Association of Coloproctology of Great Britain and Ireland position on tranexamic acid in upper and lower gastrointestinal bleeding
clinical-resource/Tranexamic-acid-in-upper-lower-GI-bleeding
Following a concern raised to NHS England’s National Patient Safety Team regarding tranexamic acid use in gastrointestinal bleeding, and in light of the 2020 publication of the HALT-IT trial results,